Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray

[1]  Virginia Espina,et al.  Protein microarrays: Molecular profiling technologies for clinical specimens , 2003, Proteomics.

[2]  D. Voehringer,et al.  The MEK/ERK pathway acts upstream of NF kappa B1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis. , 2003, The Journal of biological chemistry.

[3]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[4]  R. T. Abbott,et al.  Analysis of the PI-3-Kinase-PTEN-AKT Pathway in Human Lymphoma and Leukemia Using a Cell Line Microarray , 2003, Modern Pathology.

[5]  Zhaosheng Lin,et al.  Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Emanuel F Petricoin,et al.  Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.

[7]  Andrea Califano,et al.  Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Gascoyne,et al.  Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes , 2003, British journal of haematology.

[9]  E. Haralambieva,et al.  Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. , 2003, Blood.

[10]  K. Naresh,et al.  Bcl‐2 family of proteins in indolent B‐cell non‐Hodgkin's lymphoma: Study of 116 cases , 2002, American journal of hematology.

[11]  R. Bataille,et al.  Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. , 2002, Blood.

[12]  L. Liotta,et al.  Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. , 2002, Cancer research.

[13]  A. Rosenwald,et al.  Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. , 2002, Blood.

[14]  E. Jaffe,et al.  In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. , 2002, Blood.

[15]  J. Aster,et al.  Detection of BCL2 rearrangements in follicular lymphoma. , 2002, The American journal of pathology.

[16]  Noel R. Rose,et al.  Manual of clinical laboratory immunology , 2002 .

[17]  Pan‐Chyr Yang,et al.  Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells , 2001, The Journal of Biological Chemistry.

[18]  J. Chan.  Neoplastic Hematopathology, 2nd ed. , 2001 .

[19]  John Calvin Reed,et al.  The AKT kinase is activated in multiple myeloma tumor cells. , 2001, Blood.

[20]  M. Kuo,et al.  The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway , 2001, Oncogene.

[21]  M. Saji,et al.  Overexpression and overactivation of Akt in thyroid carcinoma. , 2001, Cancer research.

[22]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[23]  John Calvin Reed,et al.  Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Stamatopoulos,et al.  Molecular insights into the immunopathogenesis of follicular lymphoma. , 2000, Immunology today.

[25]  A. Zelenetz,et al.  Translocation t(14;18) in healthy individuals: preliminary study of its association with family history and agricultural exposure. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[27]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[28]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[29]  R. Gascoyne,et al.  Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. , 1999, Human pathology.

[30]  P. Cohen,et al.  Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.

[31]  T. McDonnell,et al.  Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma. , 1999, International journal of radiation oncology, biology, physics.

[32]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[33]  P. Brousset,et al.  In vivo patterns of Bcl‐2 family protein expression in breast carcinomas in relation to apoptosis , 1999, The Journal of pathology.

[34]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[35]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[36]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[37]  D. Guinee,et al.  Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-Hodgkin's lymphomas. , 1998, Human pathology.

[38]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[39]  Joachim L. Schultze,et al.  Unbalanced Expression of Bcl-2 Family Proteins in Follicular Lymphoma: Contribution of CD40 Signaling in Promoting Survival , 1998 .

[40]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[41]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[42]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[43]  E. Smeland,et al.  Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. , 1997, Blood.

[44]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[45]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[46]  M. Rowe,et al.  Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. , 1996, Cancer research.

[47]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Meijerink,et al.  Bax mutations in cell lines derived from hematological malignancies. , 1995, Leukemia.

[49]  D. Jong,et al.  Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. , 1995, Blood.

[50]  Z. Oltvai,et al.  Checkpoints of dueling dimers foil death wishes , 1994, Cell.

[51]  R. Gascoyne,et al.  Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. , 1994, The American journal of pathology.

[52]  V. Kosma,et al.  Apoptosis in breast cancer as related to histopathological characteristics and prognosis. , 1994, European journal of cancer.

[53]  J. Sklar,et al.  Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. , 1992, The American journal of pathology.

[54]  P. Gaulard,et al.  Expression of the bcl-2 gene product in follicular lymphoma. , 1992, The American journal of pathology.

[55]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[56]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[57]  M. Raffeld,et al.  Detection of occult follicular lymphoma by specific DNA amplification. , 1988, Blood.

[58]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[59]  R. Warnke,et al.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. , 1987, The New England journal of medicine.

[60]  S. Korsmeyer,et al.  Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. , 1987, The Journal of clinical investigation.

[61]  S. Staal.  Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[62]  C. Croce,et al.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.

[63]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[64]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[65]  R. Schwartz,et al.  B cells of normal individuals produce antibodies with idiotypes shared by human lupus autoantibodies , 1984 .

[66]  R. R. Howe,et al.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.

[67]  R. Levy,et al.  Immunopathology of follicular lymphomas. A model of B-lymphocyte homing. , 1978, The New England journal of medicine.

[68]  E. Jaffe,et al.  Nodular lymphoma--evidence for origin from follicular B lymphocytes. , 1974, The New England journal of medicine.